4.8 Article

Linear ubiquitination prevents inflammation and regulates immune signalling

Journal

NATURE
Volume 471, Issue 7340, Pages 591-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature09816

Keywords

-

Funding

  1. Cancer Research UK
  2. AICR
  3. BBSRC (ERASysBio PLUS)
  4. Ovarian Cancer Action
  5. EU
  6. NHMRC [541901, 541902, 602516]
  7. HGF/SBCancer
  8. Schweizer Nationalfonds (SNF)
  9. Biotechnology and Biological Sciences Research Council [BB/I004580/1] Funding Source: researchfish
  10. Cancer Research UK [10950] Funding Source: researchfish
  11. BBSRC [BB/I004580/1] Funding Source: UKRI

Ask authors/readers for more resources

Members of the tumour necrosis factor (TNF) receptor superfamily have important functions in immunity and inflammation. Recently linear ubiquitin chains assembled by a complex containing HOIL-1 and HOIP (also known as RBCK1 and RNF31, respectively) were implicated in TNF signalling, yet their relevance in vivo remained uncertain. Here we identify SHARPIN as a third component of the linear ubiquitin chain assembly complex, recruited to the CD40 and TNF receptor signalling complexes together with its other constituents, HOIL-1 and HOIP. Mass spectrometry of TNF signalling complexes revealed RIP1 (also known as RIPK1) and NEMO (also known as IKK gamma or IKBKG) to be linearly ubiquitinated. Mutation of the Sharpin gene (Sharpin(cpdm/cpdm)) causes chronic proliferative dermatitis (cpdm) characterized by inflammatory skin lesions and defective lymphoid organogenesis. Gene induction by TNF, CD40 ligand and interleukin-1 beta was attenuated in cpdm-derived cells which were rendered sensitive to TNF-induced death. Importantly, Tnf gene deficiency prevented skin lesions in cpdm mice. We conclude that by enabling linear ubiquitination in the TNF receptor signalling complex, SHARPIN interferes with TNF-induced cell death and, thereby, prevents inflammation. Our results provide evidence for the relevance of linear ubiquitination in vivo in preventing inflammation and regulating immune signalling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available